• Activity INFORMATION

  Overview

  Naloxone saves lives by reversing opioid overdose respiratory depression, but it is not the only opioid mu-receptor antagonist available. Also, the actual administration of naloxone typically takes seconds, yet the additional clinical and situational information associated with it takes much longer to unpackage. Thus, this program will review the signs and symptoms of opioid overdose, the FDA-approved opioid overdose respiratory depression reversal products, the opioid overdose respiratory depression reversal medication administration guidelines, and general important pharmacological characteristics of the opioid antagonist’s naloxone, naltrexone, and nalmefene. Join Dr. Mark Garofoli for a dynamic discussion on just how to save a life!
  

  Handouts

  • Slide Document :   23128H99_2pp.pdf Download

  • Slide Document :   23128H99_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recall FDA-approved opioid overdose respiratory depression reversal products and administration guidelines

  Recognize opioid overdose symptoms

  Identify clinically important pharmacological characteristics of opioid antagonists naloxone, naltrexone, and nalmefene

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1035822

  Universal Activity Number

  Pharmacist 0798-0000-23-128-H99-P
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Mark  Garofoli, PharmD, MBA, BCGP, CPE, CTTS Assistant Professor, West Virginia University School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).